For the Inventor, By the Inventor

Enter assignee name

Westmount, Canada

Angiochem Inc.

USPTO Granted Patents = 17

CIPO Patents = 7

EPO Patents = 12

Forward Citations = 72

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Michel Demeule (15 out of 21 patents)

Christian Che (9 out of 9 patents)

Anthony Regina (7 out of 7 patents)

4. Jean-Paul Castaigne (6 out of 7 patents)

5. Richard Béliveau (5 out of 10 patents)

6. Richard Beliveau (5 out of 10 patents)

7. Betty Lawrence (4 out of 4 patents)

8. Catherine Gagnon (4 out of 4 patents)

9. Gaoqiang Yang (2 out of 7 patents)

10. Carine Thiot (2 out of 2 patents)

11. Reinhard Gabathuler (2 out of 5 patents)

12. Alain Larocque (1 out of 4 patents)

13. Priya Kumthekar (1 out of 1 patent)

14. Sasmita Tripathy (1 out of 9 patents)

15. Jonathan Michaud-Levesque (1 out of 3 patents)

17 patents: Sort by Forward Citations

1. 10980892 - Methods for the treatment of leptomeningeal carcinomatosis (2021-04-20),

2. 9914754 - Conjugates of neurotensin or neurotensin analogs and uses thereof (2018-03-13),

3. 9713646 - Potentiation of anticancer agents (2017-07-25),

4. 9687561 - Peptide-dendrimer conjugates and uses thereof (2017-06-27),

5. 9365634 - Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues (2016-06-14),

6. 9221867 - Method for transporting a compound across the blood-brain barrier (2015-12-29),

7. 9173891 - Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog (2015-11-03),

8. 9161988 - Multimeric peptide conjugates and uses thereof (2015-10-20),

9. 8969310 - Potentiation of anticancer agents (2015-03-03),

10. 8921314 - Conjugates of GLP-1 agonists and uses thereof (2014-12-30),

11. 8853353 - Membrane type-1 matrix metalloprotein inhibitors and uses thereof (2014-10-07),

12. 8828949 - Aprotinin polypeptides for transporting a compound across the blood-brain barrier (2014-09-09),

13. 8828925 - Etoposide and doxorubicin conjugates for drug delivery (2014-09-09),

14. 8710013 - Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use (2014-04-29),

15. 8487072 - Compounds for stimulating P-glycoprotein function and uses thereof (2013-07-16),

Angiochem Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing targeted therapeutic drugs to treat patients with cancer and vascular diseases. Using its proprietary platform technology, Angiopep, the company designs and develops peptides that can cross the blood-brain barrier to deliver therapeutic agents directly to the brain and other organs. Angiochem's innovative approach holds potential for addressing unmet medical needs in various disease areas. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#1 in Westmount

#841 in Canada

#34,861 in the World

Westmount, Canada

Angiochem Inc.

Forward Citations = 72

19 inventors:

Michel Demeule (15 out of 21 patents)

Christian Che (9 out of 9 patents)

Anthony Regina (7 out of 7 patents)

4. Jean-Paul Castaigne (6 out of 7 patents)

5. Richard Béliveau (5 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…